![PDF) Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: Analysis of effects of baseline features on treatment response PDF) Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: Analysis of effects of baseline features on treatment response](https://www.researchgate.net/publication/237069064/figure/fig2/AS:213917528793092@1428013321511/Effect-of-patient-characteristics-demographics-on-the-efficacy-of-donepezil-23mg-d-or_Q320.jpg)
PDF) Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: Analysis of effects of baseline features on treatment response
![Full article: Development of Computational Methods to Predict Protein Pocket Druggability and Profile Ligands using Structural Data Full article: Development of Computational Methods to Predict Protein Pocket Druggability and Profile Ligands using Structural Data](https://www.researchgate.net/profile/Alexandre-Borrel/publication/303999020/figure/fig4/AS:614002652626948@1523401048078/Example-of-pyruvate-phosphate-dikinase-with-bound-Mgphosphonopyruvate-binding-site_Q320.jpg)
Full article: Development of Computational Methods to Predict Protein Pocket Druggability and Profile Ligands using Structural Data
![PDF) Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: Analysis of effects of baseline features on treatment response PDF) Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: Analysis of effects of baseline features on treatment response](https://www.researchgate.net/publication/237069064/figure/fig3/AS:213917528793093@1428013321539/Effect-of-prior-10mg-treatment-duration-on-the-efficacy-of-donepezil-23mg-d-or-10mg-d_Q320.jpg)
PDF) Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: Analysis of effects of baseline features on treatment response
![PDF) Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: Analysis of effects of baseline features on treatment response PDF) Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: Analysis of effects of baseline features on treatment response](https://www.researchgate.net/publication/237069064/figure/fig1/AS:213917528793091@1428013321488/Effect-of-disease-characteristics-on-the-efficacy-of-donepezil-23mg-d-or-10mg-d-measured_Q320.jpg)
PDF) Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: Analysis of effects of baseline features on treatment response
Reviving The Broken Marionette: Treatments For CFS/ME and Fibromyalgia | PDF | Chronic Fatigue Syndrome | Fibromyalgia
![Daniel Reiche's research works | Humboldt-Universität zu Berlin, Berlin (HU Berlin) and other places Daniel Reiche's research works | Humboldt-Universität zu Berlin, Berlin (HU Berlin) and other places](https://www.researchgate.net/publication/362234796/figure/fig2/AS:11431281078787765@1660257470227/Outgoing-power-connected-to-the-fluctuating-dynamics-of-the-system-P-fluc-out-Equations_Q320.jpg)
Daniel Reiche's research works | Humboldt-Universität zu Berlin, Berlin (HU Berlin) and other places
Reviving The Broken Marionette: Treatments For CFS/ME and Fibromyalgia | PDF | Chronic Fatigue Syndrome | Fibromyalgia
![PDF) Can the general public use vignettes to discriminate between Alzheimer's disease health states? PDF) Can the general public use vignettes to discriminate between Alzheimer's disease health states?](https://i1.rgstatic.net/publication/293013667_Can_the_general_public_use_vignettes_to_discriminate_between_Alzheimer's_disease_health_states/links/56c1f80608aeedba0567c62b/largepreview.png)